Advance Search

Optimization of solid dispersion technique and gliclazide to carrier (PVP K30) ratio for solubility enhancement

Berivan Ajeel Ibrahim
Department of Pharmaceutics, College of Pharmacy, University of Duhok, Duhok, Iraq.
Nozad Rashid Hussein
Department of Pharmaceutics, College of Pharmacy, Hawler Medical University, Erbil, Iraq.
Keywords:
Copyright and Licensing:

Copyright (c) 2024 Berivan Ajeel Ibrahim, Nozad Rashid Hussein (Author)

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Share:
Crossref
Scopus
Google Scholar
Europe PMC

Abstract

Background and objective: Poorly water-soluble dugs provide less dissolution rate and bioavailability; hence, it minimizes the pharmacological effect of orally administered medications. Gliclazide is a sulfonylurea antidiabetic medication of the second generation, used to treat type II diabetes mellitus. It belongs to the class II drugs of biopharmaceutic classification system, indicating that it has high permeability and poor aqueous solubility. The aim of this study is to determine an optimum solid dispersion method and drug to carrier ratio to improve the solubility of gliclazide.

Methods: Solid dispersions of gliclazide were formulated with polyvinyl pyrrolidone K30 using various drug to carrier ratios (1:1, 1:3, and 1:5) by utilizing kneading and solvent evaporation methods. Solubility and dissolution rate of solid dispersion formulas were compared with pure drug and co-ground mixtures. The formulations were further evaluated in terms of percentage of yield, drug content, FTIR, SEM, DSC, and XRD studies.

Results: The highest solubility improvement of gliclazide was obtained at the ratio 1:5 of gliclazide and PVP K30 utilizing solvent evaporation method, solubility increased about 2.54 folds (98.299 ± 5.77 µg/ml) as compared to pure gliclazide (38.739 µg/ml). Meanwhile, the greatest improvement in gliclazide dissolution rate was observed in the same solid dispersion formula that was about 105.76 % after 30 minutes. FTIR demonstrated no unwanted interaction between the drug and carrier. While, SEM, DSC, and XRD showed crystallinity of the drug was minimized and converted to amorphous form in solid dispersion formula.

Conclusion: Based on the investigations of this study, it can be concluded that the drug to carrier weight ratios and preparation methods had the influence on the drug solubility and the release rate. The obtained data revealed that the solvent evaporation is the best method of solid dispersion for enhancing gliclazide solubility using PVP K30 with the ratio 1:5 of the drug and carrier.

PDF
PDF

Metrics

Metrics Loading ...

References

  1. Yurtdaş-Kırımlıoğlu G. Development and characterization of lyophilized cefpodoxime proxetil-Pluronic® F127/polyvinylpyrrolidone K30 solid dispersions with improved dissolution and enhanced antibacterial activity. Pharm Dev Technol 2021; 26(4):476–89. https://doi.org/10.1080/10837450.2021.1889584
  2. Da Silva FLO, Marques MBDF, Kato KC, Carneiro G. Nanonization techniques to overcome poor water-solubility with drugs. Expert Opin Drug Discov 2020; 15(7):853–64. https://doi.org/10.1080/17460441.2020.1750591
  3. Ibrahim NJ, Smail SS, Hussein NR, Abdullah TA. Solubility enhancement of nimodipine using mixed hydrotropic solid dispersion technique. Zanco J Med Sci 2020; 24(3):386–94. https://doi.org/10.15218/zjms.2020.046
  4. Kim S-J, Lee H-K, Na Y-G, Bang K-H, Lee H-J, Wang M, et al. A novel composition of ticagrelor by solid dispersion technique for increasing solubility and intestinal permeability. Int J Pharm 2019; 555:11–8. https://doi.org/10.1016/j.ijpharm.2018.11.038
  5. Deshmane S, Deshmane S, Shelke S, Biyani K. Enhancement of solubility and bioavailability of ambrisentan by solid dispersion using Daucus carota as a drug carrier: formulation, characterization, in vitro, and in vivo study. Drug Dev Ind Pharm 2018; 44(6):1001–11. https://doi.org/10.1080/03639045.2018.1428339
  6. Kurakula M, Rao GK. Pharmaceutical assessment of polyvinylpyrrolidone (PVP): As excipient from conventional to controlled delivery systems with a spotlight on COVID-19 inhibition. J Drug Deliv Sci Technol 2020; 60:102046. https://doi.org/10.1016/j.jddst.2020.102046
  7. Febriyenti F, Rahmi S, Halim A. Study of gliclazide solid dispersion systems using PVP K-30 and PEG 6000 by solvent method. J Pharm Bioallied Sci 2019; 11(3):262. https://doi.org/10.4103/jpbs.JPBS_87_18
  8. Nasr M, Almawash S, Al Saqr A, Bazeed AY, Saber S, Elagamy HI. Bioavailability and antidiabetic activity of gliclazide-loaded cubosomal nanoparticles. Pharmaceuticals 2021; 14(8):786. https://doi.org/10.3390/ph14080786
  9. Chaturvedi M, Kumar M, Pathak K, Bhatt S, Saini V. Surface solid dispersion and solid dispersion of meloxicam: comparison and product development. Adv pharm Bull 2017; 7(4):569–77. https://doi.org/10.15171/apb.2017.068
  10. Alves LDS, Soares MFdLR, de Albuquerque CT, da Silva ÉR, Vieira ACC, Fontes DAF, et al. Solid dispersion of efavirenz in PVP K-30 by conventional solvent and kneading methods. Carbohydr Polym 2014; 104:166–74. https://doi.org/10.1016/j.carbpol.2014.01.027
  11. Soni L, Ansari M, Thakre N, Singh A, Bhowmick M, Rathi J. Development and in-vitro evaluation of furosemide solid dispersion using different water soluble carriers. Int J Res Dev Pharm Life Sci 2017; 6(2):2571–5. http://dx.doi.org/10.21276/IJRDPL
  12. Yurtdaş-Kırımlıoğlu G. A promising approach to design thermosensitive in situ gel based on solid dispersions of desloratadine with Kolliphor® 188 and Pluronic® F127. J Therm Anal Calorim 2022; 147(2):1307–27. https://doi.org/10.1007/s10973-020-10460-0
  13. Kaur P, Singh SK, Garg V, Gulati M, Vaidya Y. Optimization of spray drying process for formulation of solid dispersion containing polypeptide-k powder through quality by design approach. Powder Technol 2015; 284:1–11. https://doi.org/10.1016/j.powtec.2015.06.034
  14. Oo MK, Mahmood S, Wui WT, Mandal UK, Chatterjee B. Effects of different formulation methods on drug crystallinity, drug-carrier interaction, and ex vivo permeation of a ternary solid dispersion containing nisoldipine. J Pharm Innov 2021; 16(1):26–37. https://doi.org/10.1007/s12247-019-09415-2
  15. AlKhalidi MM, Jawad FJ. Enhancement of Aqueous Solubility and Dissolution Rate of Etoricoxib by Solid Dispersion Technique. Iraqi J Pharma Sci 2020; 29(1):76–87. https://doi.org/10.31351/vol29iss1pp76-87
  16. Rizvi SSB, Akhtar N, Minhas MU, Mahmood A, Khan KU. Synthesis and Characterization of Carboxymethyl Chitosan Nanosponges with Cyclodextrin Blends for Drug Solubility Improvement. Gels 2022; 8(1):55. https://doi.org/10.3390/gels8010055
  17. Trasi NS, Bhujbal SV, Zemlyanov DY, Zhou QT, Taylor LS. Physical stability and release properties of lumefantrine amorphous solid dispersion granules prepared by a simple solvent evaporation approach. Int J Pharm X 2020; 2:100052. https://doi.org/10.1016/j.ijpx.2020.100052
  18. Hajji S, Younes I, Ghorbel-Bellaaj O, Hajji R, Rinaudo M, Nasri M, et al. Structural differences between chitin and chitosan extracted from three different marine sources. Int J Biol Macromol 2014; 65:298–306. https://doi.org/10.1016/j.ijbiomac.2014.01.045
  19. Soliman MAN, Ibrahim HK, Nour SAE-K. Diacerein solid dispersion loaded tablets for minimization of drug adverse effects: statistical design, formulation, in vitro, and in vivo evaluation. Pharm Dev Technol 2021; 26(3):302–15. https://doi.org/10.1080/10837450.2020.1869982
  20. Barzegar-Jalali M, Valizadeh H, Shadbad M-RS, Adibkia K, Mohammadi G, Farahani A, et al. Cogrinding as an approach to enhance dissolution rate of a poorly water-soluble drug (gliclazide). Powder Technol 2010; 197(3):150–8. https://doi.org/10.1016/j.powtec.2009.09.008
  21. Ismail MY, Ghareeb MM. Enhancement of the solubility and dissolution rate of rebamipide by using solid dispersion technique (Part I). Iraqi J Pharma Sci 2018; 27(2):55–65. https://doi.org/10.31351/vol27iss2pp55-65
  22. Brokešová J, Slámová M, Zámostný P, Kuentz M, Koktan J, Krejčík L, et al. Mechanistic study of dissolution enhancement by interactive mixtures of chitosan with meloxicam as model. Eur J Pharma Sci 2022; 169:106087. https://doi.org/10.1016/j.ejps.2021.106087
  23. Khattab IS, Nada A, Zaghloul A-A. Physicochemical characterization of gliclazide–macrogol solid dispersion and tablets based on optimized dispersion. Drug Dev Ind Pharm 2010; 36(8):893–902. https://doi.org/10.1007/s10973-020-10460-0
  24. Lu M, Xing H, Jiang J, Chen X, Yang T, Wang D, et al. Liquisolid technique and its applications in pharmaceutics. Asian J Pharm Sci 2017; 12(2):115–23. https://doi.org/10.1016/j.ajps.2016.09.007
  25. Savardekar RY, Sherikar AS. Screening of Ketoprofen-Poloxamer and Ketoprofen-Eudragit solid dispersions for improved physicochemical characteristics and dissolution profile. Braz J PharmSci 2020; 56. https://doi.org/10.1590/s2175-97902019000318641
  26. Varma MM, Kumar PS. Formulation and Evaluation of Gliclazide Tablets Containing PVP-K30 and Hydroxypropyl-β-cyclodextrin Solid Dispersion. Int J Pharm Sci Nanotechnol 2012; 5(2):1706–19.
  27. Dos Santos KM, Barbosa RdM, Vargas FGA, de Azevedo EP, Lins ACdS, Camara CA, et al. Development of solid dispersions of β-lapachone in PEG and PVP by solvent evaporation method. Drug Dev Ind Pharm 2018; 44(5):750–6. https://doi.org/10.1080/03639045.2017.1411942
  28. Sui X, Chu Y, Zhang J, Zhang H, Wang H, Liu T, et al. The Effect of PVP Molecular Weight on Dissolution Behavior and Physicochemical Characterization of Glycyrrhetinic Acid Solid Dispersions. Adv Polym Technol 2020; 2020. https://doi.org/10.1155/2020/8859658
  29. Fule R, Amin P. Development and evaluation of lafutidine solid dispersion via hot melt extrusion: investigating drug-polymer miscibility with advanced characterisation. Asian J Pharm Sci 2014; 9(2):92–106. https://doi.org/10.1016/j.ajps.2013.12.004
  30. Zhou B, Liu S, Yin H, Qi M, Hong M, Ren G-B. Development of gliclazide ionic liquid and the transdermal patches: An effective and noninvasive sustained release formulation to achieve hypoglycemic effects. Eur J Pharma Sci 2021; 164:105915. https://doi.org/10.1016/j.ejps.2021.105915
How to Cite
Ajeel Ibrahim, B., & Rashid Hussein, N. . (2024). Optimization of solid dispersion technique and gliclazide to carrier (PVP K30) ratio for solubility enhancement . Zanco Journal of Medical Sciences (Zanco J Med Sci), 28(2), 192–206. https://doi.org/10.15218/zjms.2024.20

Send mail to Author

Send Cancel